![]() | This article includes a list of general references, but it lacks sufficient corresponding inline citations. (April 2024) |
Jay Keasling | |
---|---|
![]() Dr. Jay D. Keasling speaking at PopTech Energy Salon 2011 in New York City | |
Alma mater | University of Nebraska-Lincoln University of Michigan |
Known for | metabolic engineering |
Awards | Bill & Melinda Gates Foundation grant, Heinz Award in Technology, the Economy & Employment |
Scientific career | |
Institutions | University of California, Berkeley, University of Nebraska-Lincoln, University of Michigan |
Thesis | Dynamics and control of bacterial plasmid replication (1991) |
Doctoral advisor | Bernhard Palsson[1] |
Doctoral students | Kristala Jones Prather |
Other notable students | Michelle C. Chang |
Website | keaslinglab |
Jay D. Keasling is a professor[ambiguous] of chemical engineering and bioengineering at the University of California, Berkeley.[2] He is also associate laboratory director for biosciences at the Lawrence Berkeley National Laboratory and chief executive officer of the Joint BioEnergy Institute.[3] He is considered one of the foremost authorities in synthetic biology, especially in the field of metabolic engineering.
Keasling was elected a member of the National Academy of Engineering in 2010 for developing synthetic biology tools to engineer the antimalarial drug artemisinin.